ILM-Blue from DORC Receives NMPA Approval in China; Expanding Global Reach
JENA, Germany, March 27, 2025 /PRNewswire/ -- ZEISS Medical Technology announced today that the ILM staining dye ILM-Blue® from DORC (Dutch Ophthalmic Research Center (International) B.V.) has received National Medical Products Administration (NMPA)...
VINSSEN Receives Type Approval for Maritime Fuel Cell Stack from RINA
SEOUL, South Korea, March 21, 2025 /PRNewswire/ -- VINSSEN, a maritime decarbonization technology specialist focused on hydrogen fuel cells and supporting systems, has received Type Approval from RINA, the Italian classification society, for its...
Rona Therapeutics Receives IND Clearance from FDA to Initiate Phase 2 Study of RN0361: an APOC3 Targeted siRNA for Management of Hypertriglyceridemia
SHANGHAI, March 17, 2025 /PRNewswire/ -- Rona Therapeutics Inc., a global leader in RNA-targeted therapeutics, announced the clearance of an Investigational New Drug (IND) by the U.S. Food and Drug Administration (FDA) for RN0361-an APOC3 targeted...
Korea Ginseng Corp. (JungKwanJang) Receives 'Tyler Award' from American Botanical Council
- The American Botanical Council (ABC) selects institutions that contribute to scientific research on natural products worldwide. CERRITOS, Calif., March 11, 2025 /PRNewswire/ -- Korea Ginseng Corp. (KGC), known for its flagship brand JungKwanJang,...
mF International Limited Receives Additional 180 Day Extension from Nasdaq to Regain Compliance with Minimum Bid Price Rule
HONG KONG, Feb. 4, 2025 /PRNewswire/ -- mF International Limited (the "Company" or "mF International") (Nasdaq: MFI), a Hong Kong-based experienced financial trading solutions provider, today announced that it has received an extension of 180...
Axonify Receives Gold and Silver in Brandon Hall Group's 2024 Excellence in Technology Awards
Recognized with Gold Award for "Best Advance in Learning Management Measurement/Business Impact Tools," Silver Award for "Best Advance in a Generative AI Solution" WATERLOO, ON, Jan. 7, 2025 /PRNewswire/ -- Axonify, a global leader in frontline...
SK bioscience Receives Approval for Global Clinical Trials of mRNA Japanese Encephalitis Vaccine Candidate
SK bioscience's first mRNA vaccine candidate is expected to enter clinical trials in Australia in February 2025, with interim results expected by 2026. Joint R&D project between SK and CEPI includes up to USD 40 million in initial funding...
Pfizer Receives Authorization from Health Authority for Its 20-valent Pneumococcal Conjugate Vaccine for Infants and Children
In Hong Kong, the 20-valent Pneumococcal Conjugate Vaccine (PCV20) that offers the broadest serotype coverage of any pediatric pneumococcal conjugate vaccine – helping to fight against 20 serotypes leading to most of the invasive pneumococcal...
24 Exchange Receives SEC Approval of its New National Securities Exchange, "24X National Exchange"
24X National Exchange Plans to be the First Exchange to Offer U.S. Equities Trading 23 Hours-Per-Day on Weekdays STAMFORD, Conn., Nov. 28, 2024 /PRNewswire/ -- 24 Exchange announced today that it has received approval from the U.S. Securities and...